Simplex Trading’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-57
Closed -$17K 8359
2019
Q3
$17K Buy
57
+42
+280% +$118 ﹤0.01% 5939
2019
Q2
$3K Sell
15
-247
-94% -$738 ﹤0.01% 6705
2019
Q1
$98K Buy
262
+152
+138% +$569 ﹤0.01% 4348
2018
Q4
$39K Buy
110
+29
+36% +$126 ﹤0.01% 4779
2018
Q3
$46K Buy
81
+79
+3,950% +$452 ﹤0.01% 5257
2018
Q2
$1K Buy
+2
New +$10 ﹤0.01% 7250
2017
Q4
Sell
-22
Closed -$1K 7072
2017
Q3
$1K Buy
+22
New +$114 ﹤0.01% 5686
2017
Q2
Sell
-410
Closed -$5K 7168
2017
Q1
$5K Buy
410
+156
+61% +$1.5K ﹤0.01% 4672
2016
Q4
$50K Buy
254
+81
+47% +$762 ﹤0.01% 2170
2016
Q3
$26K Buy
+173
New +$1.45K ﹤0.01% 2727

Simplex Trading's FOMX Position: Q1 2020 in Review

Simplex Trading sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 38,420 shares — an estimated $127K sold.

Simplex Trading first reported a position in FOMX in Q1 2017 and held it in 10 quarters. The position peaked at $127K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Simplex Trading reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Simplex Trading sold 38,420 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $127K.
  • Simplex Trading first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2017 and held it in 10 quarters.
  • Simplex Trading's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $127K in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.